Chronic Idiopathic Constipation — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for chronic idiopathic constipation. 47 active patents protecting 4 drugs from 4+ originators. First major cliff: 2027. Daily refresh.

4
Approved drugs
47
Active US patents
56/100
Avg vulnerability
—
Annual revenue covered

Originators in Chronic Idiopathic Constipation

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

AbbVie 30 patents Salix 10 patents Sucampo Pharma Llc 6 patents Braintree Labs 1 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating chronic idiopathic constipation. Each bar = one year. Y-axis scaled to peak year (15 patents).

3
26
9
27
1
28
15
31
8
32
3
33
7
34
1
37

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Linzess
LINACLOTIDE
 AbbVie 30 68 — 2026-08-30
Trulance
PLECANATIDE
 Salix 10 29 — 2028-01-30
Amitiza
LUBIPROSTONE
 Sucampo Pharma Llc 6 63 — 2027-01-23
Pizensy
LACTITOL
 Braintree Labs 1 62 — 2037-05-12

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
7304036 Linzess method of use 85 2026-08-30
7304036 Linzess method of use 85 2026-08-30
7304036 Linzess method of use 80 2026-08-30
7304036 Linzess other 80 2027-02-28
7304036 Linzess other 80 2027-02-28
7304036 Linzess other 80 2027-02-28
8748573 Linzess method of use 73 2031-10-30
8748573 Linzess method of use 73 2031-10-30
8933030 Linzess method of use 68 2031-02-17
8933030 Linzess method of use 68 2031-02-17

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
10011637 Trulance composition of matter 0 2034-06-05
7041786 Trulance composition of matter 0 2028-01-30
11142549 Trulance formulation 25 2034-06-05
9616097 Trulance formulation 25 2032-08-20
9925231 Trulance formulation 31 2031-09-15
11834521 Trulance formulation 33 2034-06-05
12146003 Trulance formulation 38 2034-06-05
11319346 Trulance formulation 39 2032-03-01
10675325 Linzess formulation 48 2031-08-11
8933030 Linzess formulation 48 2031-02-17

Related